Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Reconstituted Bay 81-8973 Factor VIII Stability Supports Its Suitability for Continuous Infusion for up to 24 Hours

John M. Teare, PhD, Jared Trefethen, Stephen Garger, Prasad Mathew, MD

Blood (2018) 132 (Supplement 1): 5043.

https://doi.org/10.1182/blood-2018-99-114976

Published: 2018

Journal Articles

Acute Hemolysis Induces Pro-Angiogenic Molecule Production and Neovascularization In Vivo

Erica M.F. Gotardo, PhD, Hanan Chweih, M.Sc., Pamela L. Brito, B.Sc, Flavia C. Leonardo, PhD, Raquel Costa, PhD, Raquel Soares, PhD, Fernando F. Costa, MD, PhD, Nicola Conran, PhD

Blood (2018) 132 (Supplement 1): 3608.

https://doi.org/10.1182/blood-2018-99-118416

Published: 2018

Journal Articles

The Ribonucleotide Reductase Inhibitor, Didox, Reduces the In Vivo Vascular Inflammation and Oxidative Stress Induced By Acute Hemolysis

Nicola Conran, PhD, Juliete A.F. Silva, PhD, Erica M.F. Gotardo, PhD, Hanan Chweih, M.Sc., Lediana I. Miguel, M.Sc., Flávia Costa Leonardo, PhD, Wilson A. Ferreira, Jr., PhD, Bo E. Hedlund, PhD, Howard L. Elford, PhD, Fernando F. Costa, MD, PhD

Blood (2018) 132 (Supplement 1): 1034.

https://doi.org/10.1182/blood-2018-99-119224

Published: 2018

Journal Articles

Assessment of Self-Administration of Romiplostim after Receipt of Home Administration Training Materials: A Cross-Sectional Study of Patients with Immune Thrombocytopenic Purpura and Caregivers

Martin Schipperus, Georgia D Kaiafa, MD PhD, Louise Taylor, Sally Wetten, James Bennett, Georg Kreuzbauer, Andy Boshier, Anouchka Seesaghur

Blood (2016) 128 (22): 4918.

https://doi.org/10.1182/blood.V128.22.4918.4918

Published: 2016

Journal Articles

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

Brandon M. Hardesty, MD, Stacy Plum, PhD, Karen Thibaudeau, PhD, Martin Lee, PhD, Amy D. Shapiro, MD

Blood (2015) 126 (23): 3498.

https://doi.org/10.1182/blood.V126.23.3498.3498

Published: 2015

Journal Articles

T-Cell Dysfunction In CLL Is Mediated Not Only By PD-1/PD-L1 But Also By PD-1/PD-L2 Interactions - Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment

Fabienne McClanahan, MD, Shaun Miller, John C. Riches, MD, Essam Ghazaly, MD, PhD, William P. Day, Melania Capasso, PhD, John Gribben, MD, DSc

Blood (2013) 122 (21): 4120.

https://doi.org/10.1182/blood.V122.21.4120.4120

Published: 2013

Journal Articles

Shelf-Life Extension Of Azacitidine: A Cancer Centre Experience On Waste and Cost Reduction In The Treatment Of Myelodysplastic Syndromes

Hany R. Guirguis, MD, Flay Charbonneau, BSc Pharm, Ivan Tyono, BSc Pharm, Matthew C. Cheung, MD, Rena Buckstein, MD

Blood (2013) 122 (21): 1749.

https://doi.org/10.1182/blood.V122.21.1749.1749

Published: 2013

Journal Articles

Anti-Myeloma Effects of Carfilzomib with Cyclophosphamide (CY) or Bendamustine (Ben).

Eric Sanchez, Mingjie Li, Cathy Wang, Haiming Chen, MD., Ph.D, James R. Berenson, MD

Blood (2012) 120 (21): 2952.

https://doi.org/10.1182/blood.V120.21.2952.2952

Published: 2012

Journal Articles

Laboratory Assays for Monitoring Rivaroxaban: In House in-Vitro Analysis and Review of Literature

Praveen Kumar Pathak, MD, Simon McRae, BMedSc, MBBS, FRACP, FRCPA, Elizabeth Duncan, Ian D Lewis, MBBS, PhD, Luen Bik To

Blood (2011) 118 (21): 4320.

https://doi.org/10.1182/blood.V118.21.4320.4320

Published: 2011

Journal Articles

Lyophilized Platelet Transfusion Does Not Constitute An Immunologic “Second Hit” In a Non-Human Primate Hemorrhagic Shock Model

Alan Anthony Strawn, MD, Paul F Hwang, MD, Thomas Davis, PhD, Eric Elster, MD, Doug Tadaki, PhD, Forest Sheppard, MD

Blood (2010) 116 (21): 3360.

https://doi.org/10.1182/blood.V116.21.3360.3360

Published: 2010

Journal Articles

Bioequivalence, Heat Stability and Reconstitution of Room Temperature Stable Recombinant Activated Factor VII (rFVIIa-RT)

Prasad Mathew, MD, Jens Bjerre, MD, David L. Cooper, MD, MBA

Blood (2008) 112 (11): 4083.

https://doi.org/10.1182/blood.V112.11.4083.4083

Published: 2008

Journal Articles

The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).

Irene M. Ghobrial, MD, Mona Melhem, Ujjal Singha, PhD, Diane George, PhD, Michael Timm, Lanie Francis, MD, Yazan Alsayed, MD, Alissa Huston, MD, G. D. Roodman, MD, PhD

Blood (2005) 106 (11): 2492.

https://doi.org/10.1182/blood.V106.11.2492.2492

Published: 2005

Journal Articles

Proteomic Analysis Identifies Differences in Multiple Myeloma (MM) Cells Sensitive and Resistant to AKT Inhibition.

Alissa Huston, MD, Alexey Leontovich, MD, Michael Timm, MD, Yazan Alsayed, MD, Ujjal Singha, PhD, Lanie Francis, MD, Ganwei Lu, PhD, Judy Anderson, Suzanne Lentzsch, MD, Irene Ghobrial, MD

Blood (2005) 106 (11): 3402.

https://doi.org/10.1182/blood.V106.11.3402.3402

Published: 2005

Journal Articles

The Role of the AKT Inhibitor Perifosine in Migration and Adhesion in Multiple Myeloma (MM).

Alissa Huston, MD, Ujjal Singha, PhD, Yazan Alsayed, MD, Lanie Francis, MD, Ganwei Lu, MD, Judy Anderson, Suzanne Lentzsch, MD, G. David Roodman, MD, PhD, Irene M. Ghobrial, MD

Blood (2005) 106 (11): 2509.

https://doi.org/10.1182/blood.V106.11.2509.2509

Published: 2005

NARROW

Reconstituted Bay 81-8973 Factor VIII Stability Supports Its Suitability for Continuous Infusion for up to 24 Hours

Acute Hemolysis Induces Pro-Angiogenic Molecule Production and Neovascularization In Vivo

The Ribonucleotide Reductase Inhibitor, Didox, Reduces the In Vivo Vascular Inflammation and Oxidative Stress Induced By Acute Hemolysis

Assessment of Self-Administration of Romiplostim after Receipt of Home Administration Training Materials: A Cross-Sectional Study of Patients with Immune Thrombocytopenic Purpura and Caregivers

Pharmacokinetics of Intravenous Infusion of Glu-Plasminogen Concentrate in Patients with Hypoplasminogenemia

T-Cell Dysfunction In CLL Is Mediated Not Only By PD-1/PD-L1 But Also By PD-1/PD-L2 Interactions - Partial Functionality Is Maintained In PD-1 Defined CD8 Subsets and This Can Be Further Promoted By Ibrutinib Treatment

Shelf-Life Extension Of Azacitidine: A Cancer Centre Experience On Waste and Cost Reduction In The Treatment Of Myelodysplastic Syndromes

Anti-Myeloma Effects of Carfilzomib with Cyclophosphamide (CY) or Bendamustine (Ben).

Laboratory Assays for Monitoring Rivaroxaban: In House in-Vitro Analysis and Review of Literature

Lyophilized Platelet Transfusion Does Not Constitute An Immunologic “Second Hit” In a Non-Human Primate Hemorrhagic Shock Model

Bioequivalence, Heat Stability and Reconstitution of Room Temperature Stable Recombinant Activated Factor VII (rFVIIa-RT)

The Role of the CXCR4 Inhibitor AMD3100 in Multiple Myeloma (MM).

Proteomic Analysis Identifies Differences in Multiple Myeloma (MM) Cells Sensitive and Resistant to AKT Inhibition.

The Role of the AKT Inhibitor Perifosine in Migration and Adhesion in Multiple Myeloma (MM).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only